Your browser doesn't support javascript.
loading
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).
Lenders, Malte; Nordbeck, Peter; Kurschat, Christine; Karabul, Nesrin; Kaufeld, Jessica; Hennermann, Julia B; Patten, Monica; Cybulla, Markus; Müntze, Jonas; Üçeyler, Nurcan; Liu, Dan; Das, Anibh M; Sommer, Claudia; Pogoda, Christian; Reiermann, Stefanie; Duning, Thomas; Gaedeke, Jens; Stumpfe, Katharina; Blaschke, Daniela; Brand, Stefan-Martin; Mann, W Alexander; Kampmann, Christoph; Muschol, Nicole; Canaan-Kühl, Sima; Brand, Eva.
Afiliação
  • Lenders M; Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
  • Nordbeck P; Department of Internal Medicine I, Comprehensive Heart Failure Center, and Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Würzburg, Germany.
  • Kurschat C; Department II of Internal Medicine, Center for Molecular Medicine Cologne and Center for Rare Diseases, University of Cologne, Cologne, Germany.
  • Karabul N; Endokrinologikum Frankfurt, Center of Hormonal and Metabolic Diseases, Rheumatology, Osteology and Neurology, Frankfurt, Germany.
  • Kaufeld J; Department of Nephrology and Hypertension, Hannover Medical School, Germany.
  • Hennermann JB; Villa Metabolica, Department for Pediatric and Adolescent Medicine, University Medical Center Mainz, Mainz, Germany.
  • Patten M; Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany.
  • Cybulla M; Department of Nephrology and Rheumatology, FGM, Center of Internal Medicine, Müllheim, Germany.
  • Müntze J; Department of Internal Medicine I, Comprehensive Heart Failure Center, and Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Würzburg, Germany.
  • Üçeyler N; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Liu D; Department of Internal Medicine I, Comprehensive Heart Failure Center, and Fabry Center for Interdisciplinary Therapy (FAZIT), University of Würzburg, Würzburg, Germany.
  • Das AM; Department of Paediatrics, Hannover Medical School, Hannover, Germany.
  • Sommer C; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Pogoda C; Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
  • Reiermann S; Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
  • Duning T; Department of Neurology, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
  • Gaedeke J; Department of Medicine, Division of Nephrology, Charité, Campus Virchow-Klinikum, Berlin, Germany.
  • Stumpfe K; Department of Pediatrics, University Medical Center Hamburg, Eppendorf, Hamburg, Germany.
  • Blaschke D; Department of Medicine, Division of Cardiology, Charité, Campus Virchow-Klinikum, Berlin, Germany.
  • Brand SM; Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
  • Mann WA; Endokrinologikum Frankfurt, Center of Hormonal and Metabolic Diseases, Rheumatology, Osteology and Neurology, Frankfurt, Germany.
  • Kampmann C; Villa Metabolica, Department for Pediatric and Adolescent Medicine, University Medical Center Mainz, Mainz, Germany.
  • Muschol N; Department of Pediatrics, University Medical Center Hamburg, Eppendorf, Hamburg, Germany.
  • Canaan-Kühl S; Department of Medicine, Division of Nephrology, Charité, Campus Virchow-Klinikum, Berlin, Germany.
  • Brand E; Department of Internal Medicine D, and Interdisciplinary Fabry Center (IFAZ), University Hospital Münster, Münster, Germany.
Clin Pharmacol Ther ; 108(2): 326-337, 2020 08.
Article em En | MEDLINE | ID: mdl-32198894

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / 1-Desoxinojirimicina / Alfa-Galactosidase Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Fabry / 1-Desoxinojirimicina / Alfa-Galactosidase Idioma: En Ano de publicação: 2020 Tipo de documento: Article